Outlook Therapeutics is trading at $0.59, up 6.00%, with no verified company-specific announcement explaining the rise.
- The latest listed press release was October 9.
- The gain is occurring during a broad risk-off session, with major U.S. indexes lower; market direction does not explain the move.
- No trading-volume figure is available in the provided price context.